http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34548608

Outgoing Links

Predicate Object
contentType Journal Article
issn 2198-3844
issueIdentifier 1
pageRange e2203298-
publicationName Advanced science (Weinheim, Baden-Wurttemberg, Germany)
startingPage e2203298
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_beeb2fa48492c7095f7ed6008d798306
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1c0aa062611518a12552a116a65f748d
bibliographicCitation Liu Q, Chu Y, Shao J, Qian H, Yang J, Sha H, Cen L, Tian M, Xu Q, Chen F, Yang Y, Wang W, Wang K, Yu L, Wei J, Liu B. Benefits of an Immunogenic Personalized Neoantigen Nanovaccine in Patients with High-Risk Gastric/Gastroesophageal Junction Cancer. Adv Sci (Weinh). 2022 Nov 09;():e2203298. PMID: 36351249; PMCID: PMC9811442.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_24d5abcd8831693ccc461585639b8d78
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13d225e0044c29c57db189ab61cbc62d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a557d91d68c92e1c845cf5671543f485
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2539-7732
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_738fc2df0160328b0854fe70e4f5811a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3ad9709562fb30756083741043f29d23
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_765c9842c77c0a907e73ff01a4d5d566
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d8f01e08a0e654032ee8dfb357331448
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_afbae19b0999cf4f0ed995db074711cd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8a7472604c4d5d4687ea83337ad8dcb2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_17d010888b6c5f7faa69d196c6681c10
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1577f78fac54cf95460035f09c1c0a21
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_130e5cb3fea22a2edd06f985ae1b1093
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bcc47eb3d97f18fbf97d374b9f65f083
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4646498f757290d67df69d3d2e2589f1
date 2022-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/36351249
https://pubmed.ncbi.nlm.nih.gov/PMC9811442
https://doi.org/10.1002/advs.202203298
isPartOf https://portal.issn.org/resource/ISSN/2198-3844
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/44166
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Benefits of an Immunogenic Personalized Neoantigen Nanovaccine in Patients with High‐Risk Gastric/Gastroesophageal Junction Cancer
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_29f84c0d894769b14b36c5f43f54153e
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b83d04d3e3b05ce10d1a5893dc850a9b
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9305

Total number of triples: 41.